Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adynxx Inc.

Stopping chronic pain before it starts

This article was originally published in Start Up

Executive Summary

Adynxx Inc.’s first clinical candidate is a one-time treatment to keep acute postoperative pain out of the brain. The same pain pathway-blocking strategy underlies a therapeutic pipeline the company plans to develop for the huge need for a better solution for the five million patients in the US who are treated for chronic pain annually.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC092389

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel